Corridor Pharmaceuticals corridorpharma.com


Public lists: Pharma Startups (4740)

Corridor Pharmaceuticals, formerly Arginetix, is a platform-based pulmonary and critical care company focused on developing therapeutics to treat inflammation, fibrosis and endothelial dysfunction. Utilizing their platform technology, the Company has discovered a highly potent, small molecule approach to inhibiting arginase. Corridor is targeting diseases where elevated arginase levels have been shown to be involved in disease progression such a pulmonary fibrosis, COPD and ischemia reperfusion ...Show all

Corridor Pharmaceuticals, formerly Arginetix, is a platform-based pulmonary and critical care company focused on developing therapeutics to treat inflammation, fibrosis and endothelial dysfunction. Utilizing their platform technology, the Company has...Show all

Company (Alive / Active)

Phone: 410-616-0916

Fax:

1122 Kenilworth Drive
Suite 401
Towson, 21204
Maryland, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Corridor Pharmaceuticals $20.7M Jan 31, 2013

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Corridor Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Ben Franklin Technology Partners of Central & Northern PAPublic-Private PartnershipState College, Pennsylvania, United States
Domain AssociatesVenture CapitalPrinceton, New Jersey, United StatesDebt, Series A
AcidophilCorporationLutherville, Maryland, United StatesSeries A
Maryland Health Care Product Development CorporationNon-Profit FoundationRockville, Maryland, United StatesSeries A
Ben Franklin Technology Partners of Southeastern PAPublic-Private PartnershipPhiladelphia, Pennsylvania, United StatesSeries A
See all 9 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Arginase inhibitors and methods of use thereof Jul 26, 2011 Nov 25, 2014 Patent